Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
Cefpiramide sodium is a third-generation cephalosporin antibiotic administered by injection for bacterial infections. It provides broad-spectrum coverage against gram-positive and gram-negative organisms. The drug works by inhibiting bacterial cell wall synthesis, making it bactericidal.
Product approaching end-of-life with moderate competitive pressure (30/100), indicating a contracting team focused on lifecycle management and transition planning rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on cefpiramide sodium offers limited growth opportunities, positioning you in a legacy product management or operations support role focused on margin optimization and transition planning. Career advancement is constrained by the product's mature lifecycle and approaching generic erosion, making this role suitable for specialists seeking stable positions rather than growth trajectories.
Worked on CEFPIRAMIDE SODIUM at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.